All GLG News Analyses Filed Under: Infectious Disease

The approval of the FDA for FluMist vaccine was based on the outcome of a large clinical trail involving young children of 6 -59 months. The nasal vaccine appears to be easy to administer without having any side effects for healthy young children. The article furthermore shows the cautionery...

This short news article highlights, in my mind, the importance of protecting species of plants and animals that may have, as of yet, undiscovered medical uses. Considering the rate of species extinction, there are an untold number of potential medical remedies that are forever being lost to humanity....

The formal approval for AIDS drug Celsentri, the first in a new class of oral HIV medicines by the European Commission is a welcoming news during an increasing incidence of AIDS in this part of the world.  The drug has also received approval from the FDA, hence the widespread use...

This news may reduce anxiety of parents with children suffering from Cystic Fibrosis for two years for finding the possibility of getting an economic product to treat mild lung disorder. The news is a relief for medical practitioners to safeguard the use of Ibuprofen to treat very young children's Cystic...

* Another HIV viral load assay in an increasingly crowded market. * Abbott has a reputation for recalls and recalcitrance in its diagnostics arena. 2007 has not been a good year for them. * Not clear this assay provides significant advantages over other assays recently obtaining FDA approval.

Mutations are so common in the HIV virus that it is really unclear if we will ever have a viable vaccine.

Sure, it's a blow when any highly anticipated vaccine (or drug, for that matter), does not live up to the hopes for it.

Cubicin® (daptomycin) has received European Commission approval for two additional indications, right sided infective endocarditis (RIE) caused by Staphylococcus aureus (SA)and bacteremia (bloodstream infection) caused by complicated skin and soft tissue infections (cSSTI)caused by this...

Daptomycin is a lipopeptide antimicrobial that has been studied for over 20 years and demonstrated effectiveness for treating MRSA, VRE and other resistant gram-positive bacteria.  However, this class of antibiotic, especially daptomycin has a history of adverse side effects such as ototoxicity...

The data in this article showed in vitro activity of ortavancin when tested in combination with other antibacterials and against primarily gram positive bacteria.  Targeted uses for ortavancin appears to be community acquired or nosocomial type infections. These areas of antimicrobial use...